Northern Trust’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-457,539
| Closed | -$6.92M | – | 4752 |
|
|
2022
Q3 | $6.92M | Buy |
457,539
+5,682
| +1% | +$66K | ﹤0.01% | 2248 |
|
|
2022
Q2 | $3.39M | Buy |
451,857
+10,001
| +2% | +$70.5K | ﹤0.01% | 2758 |
|
|
2022
Q1 | $4.02M | Sell |
441,856
-19,868
| -4% | -$153K | ﹤0.01% | 2718 |
|
|
2021
Q4 | $3.24M | Sell |
461,724
-1,051
| -0.2% | -$11K | ﹤0.01% | 2972 |
|
|
2021
Q3 | $5.28M | Sell |
462,775
-17,363
| -4% | -$254K | ﹤0.01% | 2699 |
|
|
2021
Q2 | $7.69M | Buy |
480,138
+27,377
| +6% | +$470K | ﹤0.01% | 2555 |
|
|
2021
Q1 | $8.09M | Sell |
452,761
-27,935
| -6% | -$483K | ﹤0.01% | 2436 |
|
|
2020
Q4 | $6.49M | Sell |
480,696
-12,994
| -3% | -$157K | ﹤0.01% | 2522 |
|
|
2020
Q3 | $5.81M | Sell |
493,690
-20,170
| -4% | -$246K | ﹤0.01% | 2434 |
|
|
2020
Q2 | $7.59M | Sell |
513,860
-21,290
| -4% | -$315K | ﹤0.01% | 2271 |
|
|
2020
Q1 | $7.22M | Buy |
535,150
+5,262
| +1% | +$99.8K | ﹤0.01% | 2093 |
|
|
2019
Q4 | $12.8M | Sell |
529,888
-54,316
| -9% | -$1.12M | ﹤0.01% | 2020 |
|
|
2019
Q3 | $11.2M | Buy |
584,204
+125,507
| +27% | +$2.88M | ﹤0.01% | 2073 |
|
|
2019
Q2 | $13.6M | Sell |
458,697
-38,165
| -8% | -$1.47M | ﹤0.01% | 1952 |
|
|
2019
Q1 | $23.6M | Buy |
496,862
+30,215
| +6% | +$1.33M | 0.01% | 1545 |
|
|
2018
Q4 | $16.8M | Sell |
466,647
-2,917
| -0.6% | -$137K | ﹤0.01% | 1720 |
|
|
2018
Q3 | $28.9M | Buy |
469,564
+11,329
| +2% | +$728K | 0.01% | 1483 |
|
|
2018
Q2 | $31M | Buy |
458,235
+24,687
| +6% | +$1.38M | 0.01% | 1416 |
|
|
2018
Q1 | $23.5M | Buy |
433,548
+7,348
| +2% | +$411K | 0.01% | 1561 |
|
|
2017
Q4 | $25.5M | Buy |
426,200
+164
| +0% | +$9.95K | 0.01% | 1529 |
|
|
2017
Q3 | $20.7M | Buy |
426,036
+20,920
| +5% | +$1.14M | 0.01% | 1686 |
|
|
2017
Q2 | $21.3M | Buy |
405,116
+25,254
| +7% | +$1.18M | 0.01% | 1622 |
|
|
2017
Q1 | $17.2M | Buy |
379,862
+8,162
| +2% | +$364K | 0.01% | 1734 |
|
|
2016
Q4 | $14.1M | Buy |
371,700
+35,572
| +11% | +$1.35M | ﹤0.01% | 1861 |
|
|
2016
Q3 | $12.7M | Buy |
336,128
+5,749
| +2% | +$127K | ﹤0.01% | 1904 |
|
|
2016
Q2 | $5.81M | Buy |
330,379
+53,938
| +20% | +$873K | ﹤0.01% | 2361 |
|
|
2016
Q1 | $3.5M | Sell |
276,441
-807
| -0.3% | -$12.8K | ﹤0.01% | 2650 |
|
|
2015
Q4 | $6.75M | Buy |
277,248
+21,749
| +9% | +$508K | ﹤0.01% | 2266 |
|
|
2015
Q3 | $4.53M | Buy |
255,499
+94,355
| +59% | +$1.71M | ﹤0.01% | 2496 |
|
|
2015
Q2 | $2.84M | Buy |
161,144
+13,191
| +9% | +$242K | ﹤0.01% | 2869 |
|
|
2015
Q1 | $4.64M | Buy |
147,953
+10,955
| +8% | +$318K | ﹤0.01% | 2551 |
|
|
2014
Q4 | $4M | Buy |
136,998
+846
| +0.6% | +$21.5K | ﹤0.01% | 2648 |
|
|
2014
Q3 | $2.82M | Buy |
136,152
+41,903
| +44% | +$826K | ﹤0.01% | 2876 |
|
|
2014
Q2 | $2.33M | Buy |
94,249
+627
| +0.7% | +$10.9K | ﹤0.01% | 3000 |
|
|
2014
Q1 | $1.98M | Sell |
93,622
-9,972
| -10% | -$201K | ﹤0.01% | 3138 |
|
|
2013
Q4 | $1.86M | Buy |
+103,594
| New | +$1.35M | ﹤0.01% | 3190 |
|
Northern Trust's AERI Position: Q4 2022 in Review
Northern Trust sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 457,539 shares — an estimated $6.92M sold.
Northern Trust first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $31M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Northern Trust reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Northern Trust sold 457,539 Aerie Pharmaceuticals shares in Q4 2022, an estimated $6.92M.
- Northern Trust first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
- Northern Trust's Aerie Pharmaceuticals position peaked at $31M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.